InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by WOODHOUSE DAVID J, Chairman & CEO. Insider active across 1 companies, notably NGM Biopharmaceuticals INC. In total, 4 filings have been published. The latest transaction was filed on 29 December 2021 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
€88,38012,987 shares@ €6.805346.9% of flow
Common Stock
SEC:0001209191-21-071613·
€88,38012,987 shares@ €6.805323.5% of flow
Common Stock
SEC:0001209191-21-071613:0·
€99,90115,000 shares@ €6.660153.1% of flow
Common Stock
SEC:0001209191-21-065973·
€99,90115,000 shares@ €6.660126.5% of flow
Common Stock
SEC:0001209191-21-065973:0·
4 of 4 declarations
About WOODHOUSE DAVID J
David J. Woodhouse is the CEO of NGM Biopharmaceuticals Inc. He leads the company with a vision focused on innovation in the biopharmaceutical sector. His experience is essential for strategic development.
